 Simona Zarini
Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 7 | 2023 | 1167 | 1.550 |
Why?
| | Leukotrienes | 10 | 2012 | 33 | 1.280 |
Why?
| | Eicosanoids | 7 | 2018 | 57 | 1.140 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2023 | 2159 | 0.880 |
Why?
| | 1-Acylglycerophosphocholine O-Acyltransferase | 3 | 2014 | 4 | 0.670 |
Why?
| | Mass Spectrometry | 5 | 2019 | 670 | 0.640 |
Why?
| | Neutrophils | 15 | 2017 | 1142 | 0.640 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 5 | 2019 | 171 | 0.610 |
Why?
| | Arachidonic Acid | 5 | 2017 | 117 | 0.560 |
Why?
| | Arachidonate 5-Lipoxygenase | 9 | 2017 | 43 | 0.550 |
Why?
| | Lipid Metabolism | 1 | 2019 | 473 | 0.530 |
Why?
| | Metabolomics | 1 | 2019 | 540 | 0.470 |
Why?
| | Myeloid Cells | 1 | 2014 | 127 | 0.460 |
Why?
| | Cysteine | 5 | 2011 | 184 | 0.450 |
Why?
| | Sphingolipids | 2 | 2023 | 59 | 0.430 |
Why?
| | Dinoprostone | 6 | 2022 | 193 | 0.410 |
Why?
| | Leukotriene B4 | 9 | 2012 | 45 | 0.400 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2023 | 192 | 0.360 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 211 | 0.340 |
Why?
| | Triglycerides | 2 | 2022 | 515 | 0.340 |
Why?
| | Obesity | 7 | 2023 | 2715 | 0.330 |
Why?
| | Muscle, Skeletal | 4 | 2023 | 1515 | 0.330 |
Why?
| | Peritonitis | 1 | 2009 | 79 | 0.330 |
Why?
| | Diabetic Retinopathy | 3 | 2019 | 160 | 0.320 |
Why?
| | Retina | 5 | 2019 | 278 | 0.310 |
Why?
| | Bone Marrow | 1 | 2009 | 252 | 0.310 |
Why?
| | Phospholipids | 5 | 2018 | 207 | 0.310 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 2006 | 54 | 0.310 |
Why?
| | Cell Communication | 1 | 2009 | 279 | 0.300 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 142 | 0.270 |
Why?
| | Macrophages | 5 | 2020 | 1311 | 0.270 |
Why?
| | Ceramides | 2 | 2023 | 96 | 0.260 |
Why?
| | Calcimycin | 5 | 2014 | 57 | 0.250 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 89 | 0.250 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 79 | 0.230 |
Why?
| | Arachidonic Acids | 1 | 2003 | 57 | 0.220 |
Why?
| | Leukotriene A4 | 7 | 2009 | 11 | 0.210 |
Why?
| | Mice | 20 | 2023 | 15446 | 0.210 |
Why?
| | Animals | 28 | 2023 | 33152 | 0.210 |
Why?
| | Leukotriene Antagonists | 2 | 2019 | 40 | 0.190 |
Why?
| | Lipolysis | 1 | 2020 | 42 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 78 | 0.180 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 353 | 0.180 |
Why?
| | Acetates | 1 | 2019 | 98 | 0.170 |
Why?
| | Myofibroblasts | 1 | 2020 | 118 | 0.170 |
Why?
| | Adipose Tissue | 2 | 2022 | 595 | 0.170 |
Why?
| | Receptors, Leukotriene | 2 | 2011 | 13 | 0.170 |
Why?
| | Quinolines | 1 | 2019 | 128 | 0.160 |
Why?
| | Calcium Ionophores | 2 | 2014 | 3 | 0.150 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2017 | 6 | 0.150 |
Why?
| | Endocannabinoids | 1 | 2017 | 37 | 0.150 |
Why?
| | Hydroxyeicosatetraenoic Acids | 3 | 2011 | 40 | 0.140 |
Why?
| | Humans | 30 | 2023 | 118268 | 0.140 |
Why?
| | Lysophospholipids | 2 | 2014 | 66 | 0.140 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 354 | 0.130 |
Why?
| | Ependymoglial Cells | 1 | 2014 | 6 | 0.130 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2014 | 6 | 0.130 |
Why?
| | Lipids | 1 | 2019 | 591 | 0.130 |
Why?
| | Inflammation | 6 | 2019 | 2545 | 0.130 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 23 | 0.130 |
Why?
| | Group IV Phospholipases A2 | 3 | 2014 | 46 | 0.120 |
Why?
| | Bone Marrow Cells | 3 | 2017 | 273 | 0.120 |
Why?
| | CD40 Antigens | 1 | 2014 | 79 | 0.120 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.120 |
Why?
| | Mice, Inbred C57BL | 9 | 2023 | 4887 | 0.120 |
Why?
| | Cell Membrane | 2 | 2007 | 700 | 0.120 |
Why?
| | Prostaglandins | 3 | 2011 | 78 | 0.120 |
Why?
| | Inflammation Mediators | 3 | 2009 | 497 | 0.110 |
Why?
| | Insulin | 1 | 2023 | 2157 | 0.110 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2013 | 86 | 0.110 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2018 | 482 | 0.110 |
Why?
| | Cytosol | 2 | 2020 | 214 | 0.110 |
Why?
| | Interleukin-13 | 2 | 2022 | 135 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4523 | 0.110 |
Why?
| | Models, Animal | 1 | 2014 | 349 | 0.110 |
Why?
| | Retinal Degeneration | 1 | 2012 | 31 | 0.110 |
Why?
| | Safflower Oil | 1 | 2012 | 7 | 0.110 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 108 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 3 | 2021 | 418 | 0.110 |
Why?
| | Intestinal Mucosa | 2 | 2014 | 529 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2012 | 0.110 |
Why?
| | Colitis | 1 | 2014 | 219 | 0.100 |
Why?
| | Linoleic Acid | 1 | 2012 | 41 | 0.100 |
Why?
| | Retinal Neovascularization | 1 | 2011 | 21 | 0.100 |
Why?
| | Cells, Cultured | 9 | 2017 | 4044 | 0.100 |
Why?
| | Cardiolipins | 1 | 2012 | 73 | 0.100 |
Why?
| | Papilledema | 1 | 2011 | 36 | 0.100 |
Why?
| | Leukocytes | 1 | 2012 | 284 | 0.100 |
Why?
| | Intestines | 2 | 2014 | 330 | 0.100 |
Why?
| | Phosphatidylglycerols | 1 | 2011 | 20 | 0.100 |
Why?
| | Retinal Diseases | 1 | 2011 | 81 | 0.100 |
Why?
| | Mycoplasma pneumoniae | 1 | 2011 | 33 | 0.100 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2011 | 33 | 0.100 |
Why?
| | Phospholipases A2, Cytosolic | 1 | 2010 | 6 | 0.090 |
Why?
| | Zebrafish | 1 | 2014 | 420 | 0.090 |
Why?
| | Leukotriene C4 | 3 | 2012 | 13 | 0.090 |
Why?
| | Subcutaneous Fat | 2 | 2022 | 78 | 0.090 |
Why?
| | Bone Marrow Transplantation | 2 | 2009 | 244 | 0.090 |
Why?
| | Synovial Membrane | 1 | 2010 | 72 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2010 | 72 | 0.090 |
Why?
| | Neuroglia | 2 | 2009 | 155 | 0.090 |
Why?
| | Thimerosal | 2 | 2008 | 4 | 0.090 |
Why?
| | Pulmonary Surfactants | 1 | 2011 | 98 | 0.090 |
Why?
| | Shock, Hemorrhagic | 1 | 2012 | 160 | 0.090 |
Why?
| | Ionophores | 3 | 2006 | 25 | 0.090 |
Why?
| | Retinal Vessels | 3 | 2019 | 53 | 0.090 |
Why?
| | Heart Failure | 2 | 2013 | 1967 | 0.090 |
Why?
| | Rats | 5 | 2022 | 5339 | 0.090 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2004 | 131 | 0.090 |
Why?
| | Mice, Knockout | 6 | 2014 | 2664 | 0.090 |
Why?
| | Zymosan | 1 | 2009 | 65 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2014 | 717 | 0.090 |
Why?
| | Mitochondria | 2 | 2012 | 785 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 278 | 0.080 |
Why?
| | Arthritis, Experimental | 1 | 2010 | 133 | 0.080 |
Why?
| | Calcium | 2 | 2006 | 1151 | 0.080 |
Why?
| | Enzymes | 1 | 2009 | 66 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1159 | 0.080 |
Why?
| | Metabolic Networks and Pathways | 1 | 2009 | 175 | 0.080 |
Why?
| | Lysophosphatidylcholines | 1 | 2007 | 26 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 355 | 0.080 |
Why?
| | Pyrazoles | 1 | 2010 | 363 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 444 | 0.070 |
Why?
| | Adenosine Triphosphatases | 1 | 2007 | 158 | 0.070 |
Why?
| | Athletes | 2 | 2020 | 342 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2477 | 0.070 |
Why?
| | Blotting, Western | 4 | 2012 | 1186 | 0.070 |
Why?
| | Isoprostanes | 1 | 2005 | 5 | 0.070 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 6 | 0.070 |
Why?
| | Thromboxanes | 1 | 2005 | 16 | 0.070 |
Why?
| | Hyperglycemia | 1 | 2009 | 313 | 0.070 |
Why?
| | Fibroblasts | 1 | 2010 | 835 | 0.070 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2006 | 131 | 0.070 |
Why?
| | Phospholipases A | 1 | 2006 | 95 | 0.070 |
Why?
| | Capillary Permeability | 2 | 2019 | 138 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2013 | 3676 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2011 | 762 | 0.060 |
Why?
| | Protein C | 1 | 2004 | 42 | 0.060 |
Why?
| | SRS-A | 1 | 2004 | 28 | 0.060 |
Why?
| | Receptors, IgE | 1 | 2004 | 40 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2007 | 347 | 0.060 |
Why?
| | Ubiquinone | 1 | 2023 | 23 | 0.060 |
Why?
| | Membrane Proteins | 3 | 2008 | 1048 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2006 | 810 | 0.060 |
Why?
| | Bronchial Hyperreactivity | 1 | 2004 | 95 | 0.060 |
Why?
| | Brain Edema | 1 | 2004 | 61 | 0.060 |
Why?
| | Electron Transport | 1 | 2023 | 101 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 1 | 2007 | 494 | 0.060 |
Why?
| | Mast Cells | 1 | 2004 | 115 | 0.060 |
Why?
| | Rats, Inbred SHR | 2 | 2013 | 42 | 0.060 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.060 |
Why?
| | Subcellular Fractions | 1 | 2003 | 83 | 0.060 |
Why?
| | Chromatography, Gel | 1 | 2003 | 133 | 0.060 |
Why?
| | Sodium | 1 | 2004 | 200 | 0.060 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 23 | 0.060 |
Why?
| | Adjuvants, Immunologic | 1 | 2004 | 207 | 0.060 |
Why?
| | Mice, Inbred ICR | 1 | 2003 | 111 | 0.060 |
Why?
| | Adipokines | 1 | 2022 | 43 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 74 | 0.050 |
Why?
| | Encephalitis | 1 | 2004 | 127 | 0.050 |
Why?
| | Glucose | 2 | 2022 | 940 | 0.050 |
Why?
| | Superoxides | 2 | 2019 | 195 | 0.050 |
Why?
| | Lipoxygenase Inhibitors | 3 | 2012 | 36 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 240 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1937 | 0.050 |
Why?
| | Glutathione Transferase | 2 | 2000 | 97 | 0.050 |
Why?
| | Prostaglandins E, Synthetic | 1 | 2000 | 2 | 0.050 |
Why?
| | Peroxidases | 1 | 2000 | 29 | 0.050 |
Why?
| | Sarcolemma | 1 | 2020 | 29 | 0.050 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 61 | 0.050 |
Why?
| | Diglycerides | 1 | 2020 | 56 | 0.050 |
Why?
| | Lung Diseases, Obstructive | 1 | 2000 | 44 | 0.050 |
Why?
| | Allergens | 1 | 2004 | 425 | 0.050 |
Why?
| | Bronchitis | 1 | 2000 | 39 | 0.050 |
Why?
| | Vitamin E | 1 | 2001 | 115 | 0.050 |
Why?
| | Organotin Compounds | 1 | 2000 | 3 | 0.050 |
Why?
| | Substrate Specificity | 3 | 2008 | 369 | 0.050 |
Why?
| | Myocardium | 2 | 2013 | 965 | 0.050 |
Why?
| | Serine | 1 | 2021 | 137 | 0.050 |
Why?
| | Muscle, Smooth | 1 | 2000 | 157 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 548 | 0.050 |
Why?
| | Mitochondria, Muscle | 1 | 2020 | 97 | 0.040 |
Why?
| | Plant Oils | 1 | 1999 | 28 | 0.040 |
Why?
| | Electroretinography | 1 | 2019 | 41 | 0.040 |
Why?
| | Cyclopropanes | 1 | 2019 | 80 | 0.040 |
Why?
| | Food Handling | 1 | 1999 | 48 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 231 | 0.040 |
Why?
| | Indoles | 3 | 2012 | 311 | 0.040 |
Why?
| | Neurons | 1 | 2007 | 1340 | 0.040 |
Why?
| | Time Factors | 2 | 2008 | 6368 | 0.040 |
Why?
| | Phenols | 1 | 1999 | 85 | 0.040 |
Why?
| | Sulfides | 1 | 2019 | 96 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 685 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2435 | 0.040 |
Why?
| | Adipocytes | 1 | 2020 | 195 | 0.040 |
Why?
| | Endoplasmic Reticulum | 1 | 2020 | 240 | 0.040 |
Why?
| | Dietary Fats | 1 | 2020 | 323 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1590 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 154 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 980 | 0.040 |
Why?
| | Male | 7 | 2020 | 57479 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2019 | 194 | 0.040 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2019 | 162 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 42 | 0.040 |
Why?
| | Endothelium, Vascular | 3 | 2011 | 890 | 0.040 |
Why?
| | Lipoxygenase | 1 | 2017 | 12 | 0.040 |
Why?
| | Lung Diseases | 1 | 2004 | 709 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2020 | 577 | 0.040 |
Why?
| | Hypersensitivity | 1 | 2001 | 270 | 0.040 |
Why?
| | Cyclic AMP | 1 | 2017 | 240 | 0.040 |
Why?
| | Glycerol | 1 | 2017 | 87 | 0.040 |
Why?
| | Immunoblotting | 1 | 2017 | 304 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 410 | 0.040 |
Why?
| | Cytokines | 2 | 2014 | 1880 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 979 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2014 | 1288 | 0.030 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 167 | 0.030 |
Why?
| | Skin | 1 | 2020 | 657 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 564 | 0.030 |
Why?
| | Signal Transduction | 3 | 2017 | 4688 | 0.030 |
Why?
| | Prostaglandin-E Synthases | 1 | 2014 | 6 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2009 | 2657 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2014 | 59 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2014 | 124 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2014 | 167 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 1004 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 857 | 0.030 |
Why?
| | Female | 6 | 2020 | 61268 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1681 | 0.030 |
Why?
| | Transplantation Chimera | 1 | 2012 | 51 | 0.030 |
Why?
| | Caspases | 1 | 2013 | 267 | 0.030 |
Why?
| | Capillaries | 1 | 2012 | 102 | 0.030 |
Why?
| | Adult | 4 | 2020 | 31327 | 0.030 |
Why?
| | Peroxidase | 1 | 2012 | 168 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 523 | 0.030 |
Why?
| | Pericytes | 1 | 2011 | 24 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 67 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 398 | 0.020 |
Why?
| | Albumins | 1 | 2011 | 100 | 0.020 |
Why?
| | Lipopeptides | 1 | 2011 | 16 | 0.020 |
Why?
| | Middle Aged | 3 | 2020 | 27514 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 116 | 0.020 |
Why?
| | Celecoxib | 1 | 2010 | 38 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 139 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2011 | 167 | 0.020 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2009 | 8 | 0.020 |
Why?
| | Lipoproteins | 1 | 2011 | 163 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 817 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 409 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 605 | 0.020 |
Why?
| | Biological Transport | 2 | 2004 | 380 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1002 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2008 | 21 | 0.020 |
Why?
| | Acyltransferases | 1 | 2008 | 52 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 817 | 0.020 |
Why?
| | Heart | 1 | 2012 | 630 | 0.020 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2007 | 8 | 0.020 |
Why?
| | Cell Count | 2 | 2000 | 315 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 438 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2007 | 73 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 28 | 0.020 |
Why?
| | Asthma | 1 | 2001 | 2143 | 0.020 |
Why?
| | Phosphatidylethanolamines | 1 | 2007 | 66 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1082 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2008 | 541 | 0.020 |
Why?
| | Rabbits | 2 | 1999 | 779 | 0.020 |
Why?
| | Oxygen | 1 | 2011 | 854 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2007 | 206 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 125 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2007 | 136 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1482 | 0.020 |
Why?
| | Lung | 2 | 2012 | 3623 | 0.020 |
Why?
| | Blood Platelets | 2 | 2000 | 344 | 0.020 |
Why?
| | Gene Deletion | 1 | 2007 | 359 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9319 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 1656 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2693 | 0.020 |
Why?
| | Goblet Cells | 1 | 2004 | 17 | 0.020 |
Why?
| | Leukopenia | 1 | 2004 | 26 | 0.020 |
Why?
| | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2004 | 4 | 0.020 |
Why?
| | Benzopyrans | 1 | 2004 | 25 | 0.020 |
Why?
| | Biomarkers | 1 | 2014 | 3568 | 0.020 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2004 | 20 | 0.020 |
Why?
| | Ovalbumin | 1 | 2004 | 165 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2004 | 151 | 0.010 |
Why?
| | Nebulizers and Vaporizers | 1 | 2004 | 80 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2004 | 279 | 0.010 |
Why?
| | Hyperplasia | 1 | 2004 | 170 | 0.010 |
Why?
| | Adoptive Transfer | 1 | 2004 | 203 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 274 | 0.010 |
Why?
| | Microcirculation | 1 | 2004 | 152 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2004 | 268 | 0.010 |
Why?
| | Endotoxins | 1 | 2004 | 234 | 0.010 |
Why?
| | Acetylcholine | 1 | 2004 | 208 | 0.010 |
Why?
| | Blood-Brain Barrier | 1 | 2004 | 108 | 0.010 |
Why?
| | Organ Size | 1 | 2004 | 460 | 0.010 |
Why?
| | Aerosols | 1 | 2004 | 221 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 435 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2004 | 528 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 2004 | 366 | 0.010 |
Why?
| | Trachea | 1 | 2004 | 225 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2434 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1202 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1302 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1701 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2000 | 92 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 194 | 0.010 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2000 | 16 | 0.010 |
Why?
| | Adenylyl Cyclases | 1 | 2000 | 86 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2461 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 303 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2004 | 1683 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2004 | 785 | 0.010 |
Why?
| | Olive Oil | 1 | 1999 | 4 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 297 | 0.010 |
Why?
| | Waste Management | 1 | 1999 | 7 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 88 | 0.010 |
Why?
| | Bronchi | 1 | 2000 | 241 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 1999 | 138 | 0.010 |
Why?
| | Sputum | 1 | 2000 | 291 | 0.010 |
Why?
| | Epoxide Hydrolases | 1 | 1997 | 9 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1998 | 26 | 0.010 |
Why?
| | Perfusion | 1 | 1997 | 152 | 0.010 |
Why?
| | Chemotaxis | 1 | 1998 | 135 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1045 | 0.010 |
Why?
| | Thiophenes | 1 | 1997 | 106 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1631 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1221 | 0.010 |
Why?
| | Erythrocytes | 1 | 1997 | 619 | 0.010 |
Why?
| | Brain | 1 | 2004 | 2481 | 0.010 |
Why?
| | Adolescent | 1 | 2004 | 18364 | 0.000 |
Why?
| | Aged | 1 | 2000 | 19599 | 0.000 |
Why?
|
|
Zarini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|